Multiple factors impact commerical launch in Oncology - it is essential that the below job titles attend this event to prepare and create product success

• VPs, Heads, Directors and Managers of Oncology Market Access: With so much change and innovation, as well as tightening regulations and restricted budget - gaining access for your therapies is a huge challenge in this critical and tough market. The insights and networking from this event guarantee you'll leave with knowledge and contacts to prepare to launch in 2012 - New for 2012: Stakeholder presentations from Specialty Pharmacy, Payers, Patient Groups & KOL's.
  Check out the full agenda and speaker line up now

• VPs, Heads, Directors and Managers of Marketing: More budget? Less budget? Right audience? Right product? These familiar challenges have been magnified by the advent of personalised medicine. This event is essential for any marketer adapting to the changing marketing environment in Oncology. New for 2012: a Targeted Therapy & Companion Diagnostic focus to give you the tools to stay on top - not one to miss.
  Check out the full agenda and speaker line up now

• VP, Heads, Director and Managers of Sales: Sales and marketing face the same pressures and are moving ever closer together. Understanding the common challenges allow to work together and the seize the common opportunities. Its important that everyone involved and associated is up to date with the latest tricks and tactics. New for 2012: Focus on Oncologist and Hospital group engagement and focus developing digital communication channels.
  Check out the full agenda and speaker line up now

• VP, Heads, Director and Managers of Business intelligence: It's essential to understand that orphan & targeted therapies require a different approach to finding your population- there is no substitute for face to face networking and learning with peers in tackling this shared industry hurdle. New for 2012: An exploration of developing techniques to identify targeted populations.
  Check out the full agenda and speaker line up now